|
Tools for Grantees: |
A Guide To Primary Care For
People With HIV/AIDS, 2004 edition |
<
Previous
| Home
| Next
>
Introduction
Editors
TOP
John G. Bartlett, MD
Professor of Medicine
Chief, Division of Infectious Diseases
Director, AIDS Service
The Johns Hopkins University School of Medicine
Baltimore, Maryland
Laura W. Cheever, MD, ScM
Deputy Associate Administrator
Chief Medical Officer
HIV/AIDS Bureau
Health Resources and Services Administration
Rockville, Maryland
Michael P. Johnson, MD, MPH
Director, Office of Global AIDS
Office of Global Health Affairs, Office of the Secretary
Department of Health and Human Services
Washington, D.C.
Douglas S. Paauw, MD, FACP
Professor of Medicine
Rathmann Family Foundation Endowed Chair for Patient-Centered Clinical Education
University of Washington School of Medicine
Seattle, Washington
Dedication TOP
A Guide to Primary Care of People with HIV/AIDS is dedicated to all the men and women working in the Ryan White CARE Act programs. Their commitment and dedication to serving people living with HIV and AIDS makes these programs possible.
Acknowledgements
TOP
Helen Schietinger
managed the development and production of the guide.
Joan Holloway
oversaw its conception and execution.
Cover design
and layout was done by Laura Spofford.
Design and
layout of the book was done by Patrice Lincoln.
Frances Porcher
and Helen Schietinger copyedited the text, and Bill Todd created
the index.
Contributing
Authors
TOP
Bruce D.
Agins, MD, MPH
Medical Director, New York State Department of Health AIDS Institute,
New York, New York
Carla S.
Alexander, MD
Assistant Professor of Medicine, Medical Director of Palliative
Care, Institute of Human Virology, University of Maryland School
of Medicine, Baltimore, Maryland
John G.
Bartlett, MD
Professor of Medicine Chief, Division of Infectious Diseases, Director,
AIDS Service, The John Hopkins University School of Medicine, Baltimore,
Maryland
Constance
A. Benson, MD
Professor of Medicine, Division of Infectious Diseases, University
of Colorado Health Sciences Center, Denver, Colorado
Kennita
R. Carter, MD
Clinical Assistant Professor, Department of Hematology/Oncology,
Veterans Administration Medical Center, Baltimore, Maryland
Gloria A.
Casale, MD, MSPH
Adjunct Professor, University of St. Francis, Adjunct Professor,
University of New Mexico School of Medicine, Albuquerque, New Mexico
Laura W.
Cheever, MD, ScM
Deputy Associate Administrator, Chief Medical Officer, HIV/AIDS
Bureau Health Resources and Services Administration, Rockville,
Maryland
Jonathan
Allen Cohn, MD, MS, FACP
Associate Professor of Medicine, Wayne State University School of
Medicine, Detroit, Michigan
Niccolo
D. Della Penna, MD
Department of Psychiatry and Behavioral Sciences, The Johns Hopkins
University School of Medicine, Baltimore, Maryland
Henry Francis,
MD
Director, Center on AIDS and Other Medical Consequences of Drug
Abuse, National Institute on Drug Abuse, National Institutes of
Health, Rockville, Maryland
Linda Frank,
PhD, MSN, ACRN
Assistant Professor, Graduate School of Public Health, University
of Pittsburgh, Pittsburgh, Pennsylvania
Michael
P. Johnson, MD, MPH
Director, Office of Global AIDS, Office of Global Health Affairs,
Office of the Secretary, Department of Health and Human Services,
Washington, DC
John McNeil,
MD
Chief, Infectious Diseases, Howard University Hospital, Washington,
DC
José
Rafael Morales, MD, FACOG
Associate Director for Clinical Affairs, Division of Community Based
Programs, HIV/AIDS Bureau, Health Resources and Services Administration,
Rockville, Maryland
Tara Evans
Nysoe, MD
Department of Medicine, University of Washington School of Medicine,
Seattle, Washington
Douglas
S. Paauw, MD, FACP
Professor of Medicine, Rathmann Family Foundation Endowed Chair
for Patient-Centered Clinical Education, Division of General Internal
Medicine, University of Washington, School of Medicine, Seattle,
Washington
María
del Carmen Ríos, MD, MPH
Acting Chief, Northeastern Regional Branch, Division of Community
Based Programs, HIV/AIDS Bureau, Health Resources and Services Administration,
Rockville, Maryland
John V.
L. Sheffield, MD
Associate Professor of Medicine, Division of General Internal Medicine,
University of Washington, School of Medicine, Seattle, Washington
Renslow
Sherer, MD
Director, Coordinated HIV Services, The CORE Center Cook County
Hospital, Chicago, Illinois
David H.
Spach, MD
Associate Professor of Medicine, Division of Infectious Diseases,
Department of Medicine, University of Washington Medical Center,
Seattle, Washington
Caroline
J. Teter, PA-C, MPH
Project Coordinator, AIDS Education and Training Center National
Resource Center, Cook County Hospital, Chicago, Illinois
Glenn J.
Treisman, MD, PhD
Associate Professor, Department of Psychiatry, The Johns Hopkins
University School of Medicine, Baltimore, Maryland
Abbreviations
TOP
ALT:
alanine aminotransferase
anti-HBc:
hepatitis B core antibody
ART:
antiretroviral therapy, highly active antiretroviral therapy
bid:
twice a day
c/mL:
copies of virus per mL
DSP:
distal symmetrical polyneuropathy
DRESS:
drug rash with eosinophilia and systemic symptoms
FTA-ABS:
fluorescent treponemal antibody absorption test for syphilis
HAART:
highly active antiretroviral therapy (see ART)
INH:
isoniazid
HCV:
hepatitis C virus
IVIG:
intravenous immune globulin
LDL:
low-density lipoprotein
LFT:
liver function test
MAC:
Mycobacterium avium complex
nPEP:
nonoccupational postexposure prophylaxis
NRTI:
nucleoside reverse transcriptase inhibitor, nucleoside
NNRTI:
non-nucleoside reverse transcriptase inhibitor
OD:
opportunistic disease
OI:
opportunistic infection
po:
per os, by mouth
PI:
protease inhibitor
PPD:
purified protein derivative of tuberculin
qd:
every day
qhs:
every night
qam:
every morning
RPR:
rapid plasma regain test for syphilis
SSRI:
selective serotonin reuptake inhibitor
STD:
sexually transmitted disease
STI:
sexually transmitted infection
TB:
tuberculosis
VDRL:
Venereal Disease Research Laboratory serologic test for syphilis
VL:
viral load
Glossary
of Antiretroviral Drugs
TOP
abacavir |
ABC |
Ziagen |
nucleoside |
amprenavir |
APV |
Agenerase |
PI |
atazanavir |
ATV |
Reyataz |
PI |
delavirdine |
DLV |
Rescriptor |
NNRTI |
didanosine |
ddI |
Videx |
nucleoside |
efavirenz |
EFV
|
Sustiva |
NNRTI |
emtricitabine |
FTC |
Emtriva |
nucleoside |
enfuvirtide |
T-20 |
Fuzeon |
fusion
inhibitor |
fosamprenavir |
FPV |
Lexiva |
PI |
indinavir |
IDV |
Crixivan |
PI |
lamivudine |
3TC |
Epivir |
nucleoside |
lopinavir
+ ritonavir |
LPV/r
|
Kaletra |
PIs |
nelfinavir |
NFV |
Viracept |
PI |
nevirapine |
NVP |
Viramine |
NNRTI |
ritonavir |
RTV |
Norvir |
PI |
saquinavir |
SQV
soft gel cap |
Fortovase |
PI |
saquinavir |
SQV
hard gel cap |
Invirase |
PI |
stavudine |
d4T |
Zerit |
nucleoside |
tenofovir |
TDF |
Viread |
nucleotide |
zalcitabine |
ddC |
Hivid |
nucleoside |
zidovudine |
AZT,
ZDV |
Retrovir |
nucleoside |
zidovudine
+ lamivudine |
AZT
+ 3TC |
Combivir |
nucleosides |
zidovudine
+ lamivudine + abacavir |
AZT
+ 3TC + ABC |
Trizivir |
nucleosides |
PI:
Protease Inhibitor
NNRTI:
non-nucleoside reverse transcriptase inhibitor
nucleoside:
nucleoside reverse transcriptase inhibitor (NRTI)
|